These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1967072)

  • 1. Early events of fusion between Epstein Barr virus and human lymphoblastoid cells (Raji) detected by R18 fluorescence dequenching measurements.
    Pozzi D; Zompetta C; Faggioni A; Lisi A; De Ros I; Ravagnan G; Grimaldi S
    Membr Biochem; 1990; 9(4):239-51. PubMed ID: 1967072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charge and pH effect on the early events of Epstein-Barr virus fusion with lymphoblastoid cells (Raji).
    Pozzi D; Faggioni A; Zompetta C; De Ros I; Lio S; Lisi A; Ravagnan G; Frati L; Grimaldi S
    Intervirology; 1992; 33(4):173-9. PubMed ID: 1326496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumor-promoting phorbol esters requires active protein kinase C.
    Davies AH; Grand RJ; Evans FJ; Rickinson AB
    J Virol; 1991 Dec; 65(12):6838-44. PubMed ID: 1658377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus enters B cells and epithelial cells by different routes.
    Miller N; Hutt-Fletcher LM
    J Virol; 1992 Jun; 66(6):3409-14. PubMed ID: 1316456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV membrane receptor (CR2) is phosphorylated by protein kinase C (PKC) in the early stages of virus entry into lymphoblastoid cells line (Raji).
    Aquino A; Lisi A; Pozzi D; Ravagnan G; Grimaldi S
    Biochem Biophys Res Commun; 1993 Oct; 196(2):794-802. PubMed ID: 7694579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of protein kinase C inhibitors with different action mechanisms on Epstein-Barr virus replication.
    Hayashi K
    Intervirology; 1992; 33(4):217-24. PubMed ID: 1326499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus infectivity of Raji and Molt 4 cells: differences in cellular membrane lipids and apparent microviscosity.
    Patel RA; Hutt-Fletcher LM; Crews FT
    Virology; 1993 Jul; 195(1):121-31. PubMed ID: 8391180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TPA induction of Epstein-Barr virus early antigens in Raji cells is blocked by selective protein kinase-C inhibitors.
    Lazdins J; Zompetta C; Grimaldi S; Barile G; Venanzoni M; Frati L; Faggioni A
    Int J Cancer; 1987 Dec; 40(6):846-9. PubMed ID: 2826340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus internalization and infectivity are blocked by selective protein kinase C inhibitors.
    Cirone M; Angeloni A; Barile G; Zompetta C; Venanzoni M; Torrisi MR; Frati L; Faggioni A
    Int J Cancer; 1990 Mar; 45(3):490-3. PubMed ID: 2155183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of EBV with the surface of receptor-negative human hepatoma cell line Li7A permits virus penetration and infection.
    Lisi A; Pozzi D; Carloni G; Da Villa G; Iacovacci S; Valli MB; Grimaldi S
    Res Virol; 1995; 146(4):295-300. PubMed ID: 8539493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of virus enzymes by phorbol esters and n-butyrate in Epstein-Barr virus genome-carrying Raji cells.
    Nutter LM; Grill SP; Li JS; Tan RS; Cheng YC
    Cancer Res; 1987 Aug; 47(16):4407-12. PubMed ID: 3038311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
    Allday MJ; Crawford DH; Thomas JA
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acidic pH triggers LCMV membrane fusion activity and conformational change in the glycoprotein spike.
    Di Simone C; Zandonatti MA; Buchmeier MJ
    Virology; 1994 Feb; 198(2):455-65. PubMed ID: 8291229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
    Gradoville L; Kwa D; El-Guindy A; Miller G
    J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell fusion by nasopharyngeal carcinoma-derived Epstein-Barr virus.
    Takimoto T; Sato H; Ogura H; Miyazaki T
    Arch Otolaryngol Head Neck Surg; 1987 May; 113(5):510-3. PubMed ID: 3032215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of membrane fluidity in Epstein Barr virus (EBV) infectivity on Akata cell line.
    Pozzi D; Lisi A; Lanzilli G; Grimaldi S
    Biochim Biophys Acta; 1996 Apr; 1280(1):161-8. PubMed ID: 8634311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of fusion of respiratory syncytial virus with HEp-2 cells as measured by R18 fluorescence dequenching assay.
    Srinivasakumar N; Ogra PL; Flanagan TD
    J Virol; 1991 Aug; 65(8):4063-9. PubMed ID: 1906550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization process.
    Nemerow GR; Cooper NR
    Virology; 1984 Jan; 132(1):186-98. PubMed ID: 6320532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation of a hydrocarbon fluorescent probe between Epstein-Barr virus and lymphoid cells: an assay for early events in viral infection.
    Rosenthal KS; Yanovich S; Inbar M; Strominger JL
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):5076-80. PubMed ID: 217012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells.
    Haddad RS; Hutt-Fletcher LM
    J Virol; 1989 Dec; 63(12):4998-5005. PubMed ID: 2555536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.